Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 6, 2009 - Issue 12
Submit an article Journal homepage
507
Views
157
CrossRef citations to date
0
Altmetric
Reviews

Drug delivery from ordered mesoporous matrices

Miguel Manzano Universidad Complutense de Madrid, Departamento de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, E-28040-Madrid, Spain; Centro de Investigación Biomédica en Red. Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, Spain +34 91 394 1861; +34 91 394 1786; [email protected]
,
Montserrat Colilla Universidad Complutense de Madrid, Departamento de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, E-28040-Madrid, Spain; Centro de Investigación Biomédica en Red. Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, Spain +34 91 394 1861; +34 91 394 1786; [email protected]
&
María Vallet-Regí Universidad Complutense de Madrid, Departamento de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, E-28040-Madrid, Spain; Centro de Investigación Biomédica en Red. Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, Spain +34 91 394 1861; +34 91 394 1786; [email protected]
Pages 1383-1400 | Published online: 26 Nov 2009

Bibliography

  • Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem-Int Edit 2007;46:7548-58
  • Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem Eur J 2006;12:5934-43.
  • Vallet-Regí M, Balas F, Colilla M, Bioceramics and pharmaceuticals: a remarkable synergy. Solid State Sci 2007;9:768-76.
  • Slowing, II, Trewyn BG, Giri S, Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater 2007;17:1225-36
  • Colilla M, Manzano M, Vallet-Regí M. Recent advances in ceramic implants as drug delivery systems for biomedical applications. Int J Nanomed 2008;3:403-14
  • Wang S. Ordered mesoporous materials for drug delivery. Microporous Mesoporous Mater 2009;117:1-9
  • Trewyn BG, Giri S, Slowing, II, Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun 2007;3236-45.
  • Kresge CT, Leonowicz ME, Roth WJ, Ordered mesoporous molecular-sieves synthesized by a liquid-crystal template mechanism. Nature 1992;359:710-2
  • Yanagisawa T, Shimizu T, Kuroda K, The preparation of alkyltrimethylammonium-kanemite complexes and their conversion to microporous materials. Bull Chem Soc Jpn 1990;63:988-92
  • Zhao DY, Feng JL, Huo QS, Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 1998;279:548-52
  • Zhao DY, Huo QS, Feng JL, Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. J Am Chem Soc 1998;120:6024-36
  • Huo QS, Margolese DI, Ciesla U, Generalized synthesis of periodic surfactant inorganic composite-materials. Nature 1994;368:317-21
  • Sakamoto Y, Kim TW, Ryoo R, Terasaki O. Three-dimensional structure of large-pore mesoporous cubic Ia(3)over-bard silica with complementary pores and its carbon replica by electron crystallography. Angew Chem-Int Edit 2004;43:5231-4
  • Huo QS, Margolese DI, Stucky GD. Surfactant control of phases in the synthesis of mesoporous silica-based materials Chem Mater 1996;8:1147-60
  • Ryoo R, Joo SH, Kim, JM. Energetically favored formation of MCM-48 from cationic-neutral surfactant mixtures. J Phys Chem B 1999;103:7435-40
  • Kim TW, Ryoo R, Kruk M, Tailoring the pore structure of SBA-16 silica molecular sieve through the use of copolymer blends and control of synthesis temperature and time. J Phys Chem B 2004;108:11480-9
  • Hoffmann F, Cornelius M, Morell J, Froba M. Silica-based mesoporous organic-inorganic hybrid materials. Angew Chem-Int Edit 2006;45:3216-51
  • Han YJ, Stucky GD, Butle A. Mesoporous silicate sequestration and release of proteins. J Am Chem Soc, 1999; 121; 9897-8.
  • Lu YF, Fan HY, Doke N, Evaporation-induced self-assembly of hybrid bridged silsesquioxane film and particulate mesophases with integral organic functionality. J Am Chem Soc 2000;122:5258-61
  • Kecht J, Schlossbauer A, Bein T. Selective functionalization of the outer and inner surfaces in mesoporous silica nanoparticles. Chem Mater 2008;20:7207-14
  • Antochshuk V, Jaroniec M. Functionalized mesoporous materials obtained via interfacial reactions in self-assembled silica-surfactant systems. Chem Mat 2000;12:2496-501
  • Jun L, Xiangdong F, Glen EF, Hybrid mesoporous materials with functionalized monolayers. Adv Mater 1998;10:161-5
  • Vallet-Regí M, Balas F, Colilla M, Manzano M. Drug Confinement and Delivery in Ceramic Implants. Drug Metab Lett 2007;1:37-40
  • Kokubo T, Kushitani H, Sakka S, Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W3. J Biomed Mater Res 1990;24:721-34
  • Vallet-Regí M, Rámila A, del Real RP, Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mat 2001;13:308-11
  • Vallet-Regí M, Balas F, Colilla M, Manzano M. Bone-regenerative bioceramic implants with drug and protein controlled delivery capability. Prog Solid State Chem 2008;36:163-91
  • Colilla M, Izquierdo-Barba I, Vallet-Regi M. Novel biomaterials for drug delivery. Expert Opin Ther Patents 2008;18:639-56
  • Horcajada P, Rámila A, Pérez-Pariente J, Vallet-Regí M. Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater 2004;68:105-9
  • Horcajada P, Rámila A, Férey G, Vallet-Regí M. Influence of superficial organic modification of MCM-41 matrices on drug delivery rate. Solid State Sci 2006;8:1243-9
  • Muñoz B, Rámila A, Pérez-Pariente J, MCM-41 organic modification as drug delivery rate regulator. Chem Mat 2003;15:500-3
  • Song SW, Hidajat K, Kawi S. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. Langmuir 2005;21:9568-75
  • Azais T, Tourne-Peteilh C, Aussenac F, Solid-State NMR study of ibuprofen confined in MCM-41 material. Chem Mat 2006;18:6382-90
  • Tang QL, Xu Y, Wu D, Sun YH. Hydrophobicity-controlled drug delivery system from organic modified mesoporous silica. Chem Lett 2006;35:474-5
  • Tang QL, Xu Y, Wu D, Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery. J Control Release 2006;114:41-6
  • Cavallaro G, Pierro P, Palumbo FS, Drug delivery devices based on mesoporous silicate. Drug Deliv 2004;11:41-6
  • Tagliati CA, Kimura E, Nothenberg MS, Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats. Gen Pharmacol 1999;33:67-71
  • Ambrogi V, Perioli L, Marmottini F, Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. Eur J Pharm Sci 2007;32:216-22
  • Zeng W, Qian XF, Zhang YB, Organic modified mesoporous MCM-41 through solvothermal process as drug delivery system. Mater Res Bull 2005;40:766-72
  • Rogers-Foy JM, Powers DL, Brosnan DA, Hydroxyapatite composites designed for antibiotic drug delivery and bone reconstruction: A caprine model. J Invest Surg 1999;12:263-75
  • Baro M, Sánchez E, Delgado A, In vitro-in vivo characterization of gentamicin bone implants. J Control Release 2002;83:353-64
  • Caliceti P, Salmaso S, Lante A, Controlled release of biomolecules from temperature-sensitive hydrogels prepared by radiation polymerization. J Control Release 2001;75:173-81
  • Changez M, Burugapalli K, Koul V, Choudhary V. The effect of composition of poly(acrylic acid)-gelatin hydrogel on gentamicin sulphate release: in vitro. Biomaterials 2003;24:527-36
  • Virto MR, Frutos P, Torrado S, Frutos G. Gentamicin release from modified acrylic bone cements with lactose and hydroxypropylmethylcellulose. Biomaterials 2003;24:79-87
  • Padilla S, del Real RP, Vallet-Regí M. In vitro release of gentamicin from OHAp/PEMA/PMMA samples. J Control Release 2002;83:343-52
  • Vallet-Regi M, Doadrio JC, Doadrio AL, Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin. Solid State Ionics 2004;172:435-9
  • Doadrio AL, Sousa EMB, Doadrio JC, Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J Control Release 2004;97:125-32
  • Xue JM, Shi M. PLGA/mesoporous silica hybrid structure for controlled drug release. J Control Release 2004;98:209-17
  • Izquierdo-Barba I, Martínez A, Doadrio AL, Release evaluation of drugs from ordered three-dimensional silica structures. Eur J Pharm Sci 2005;26:365-73
  • Doadrio JC, Sousa EMB, Izquierdo-Barba I, Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J Mater Chem 2006;16:462-6
  • Mellaerts R, Aerts CA, Van Humbeeck J, Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. Chem Commun 2007;1375-7.
  • Mellaerts R, Jammaer JAG, Van Speybroeck M, Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: A case study with itraconazole and ibuprofen. Langmuir 2008;24:8651-9
  • Mellaerts R, Mols R, Jammaer JAG, Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur J Pharm Biopharm 2008;69:223-30
  • Zelenak V, Hornebecq V, Llewellyn P. Zinc(II)-benzoato complexes immobilised in mesoporous silica host. Microporous Mesoporous Mater 2005;83:125-35
  • Qu FY, Zhu GS, Huang SY, Controlled release of captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater 2006;92:1-9
  • Qu FY, Zhu GS, Huang SY, Effective controlled release of captopril by silylation of mesoporous MCM-41. ChemPhysChem 2006;7:400-6
  • Andersson J, Rosenholm J, Areva S, Linden M. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mat 2004;16:4160-7
  • Chen F, Larsen MB, Sánchez C, Wiborg O. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. Eur Neuropsychopharmacol 2005;15:193-8
  • Nunes CD, Vaz PD, Fernandes AC, Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur J Pharm Biopharm 2007;66:357-65
  • Tang QL, Xu Y, Wu D, Sun YH. A study of carboxylic-modified mesoporous silica in controlled delivery for drug famotidine. J Solid State Chem 2006;179:1513-20
  • Xu W, Gao Q, Xu Y, Controlled drug release from bifunctionalized mesoporous silica. J Solid State Chem 2008;181:2837-44
  • Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-14
  • Nancollas GH, Tang R, Phipps RJ, Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite. Bone 2006;38:617-27
  • Russell RGG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999;25:97-106
  • Balas F, Manzano M, Horcajada P, Vallet-Regí M. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc 2006;128:8116-7
  • Nieto A, Balas F, Colilla M, Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage. Microporous Mesoporous Mater 2008;116:4-13
  • Yiu HHP, Botting CH, Botting NP, Wright PA. Size selective protein adsorption on thiol-functionalised SBA-15 mesoporous molecular sieve. Phys Chem Chem Phys 2001;3:2983-5
  • Balas F, Manzano M, Colilla M, Vallet-Regi M. L-Trp adsorption into silica mesoporous materials to promote bone formation. Acta Biomater 2008;4:514-22
  • Suva LJ, Winslow GA, Wettenhall REH, A Parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987;237:893-6
  • Pasqua L, Testa F, Aiello R, Preparation of bifunctional hybrid mesoporous silica potentially useful for drug targeting. Microporous Mesoporous Mater 2007;103:166-73
  • Lai CY, Trewyn BG, Jeftinija DM, A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 2003;125:4451-9
  • Radu DR, Lai CY, Jeftinija K, A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc 2004;126:13216-7
  • Fisher KA, Katherine DH, Joan TM. Comparison of micro- and mesoporous inorganic materials in the uptake and release of the drug model fluorescein and its analogues. Chem A Eur J 2003;9:5873-8
  • Yang Q, Wang SH, Fan PW, pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem Mat 2005;17:5999-6003
  • Leung KCF, Nguyen TD, Stoddart JF, Zink JI. Supramolecular nanovalves controlled by proton abstraction and competitive binding. Chem Mat 2006;18:5919-28
  • Nguyen TD, Leung KCF, Liong M, Construction of a pH-driven supramolecular nanovalve. Org Lett 2006;8:3363-6
  • Zhu YF, Shi JL, Shen WH, Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angew Chem-Int Edit 2005;44:5083-7
  • Xu WJ, Gao Q, Xu Y, pH-Controlled drug release from mesoporous silica tablets coated with hydroxypropyl methylcellulose phthalate. Mater Res Bull 2009;44:606-12
  • Song SW, Hidajat K, Kawi S. pH-Controllable drug release using hydrogel encapsulated mesoporous silica. Chem Commun 2007;4396-8
  • Chiyoung P, Kyoungho O, Sang Cheon L, Chulhee K. Controlled release of guest molecules from mesoporous silica particles bbased on a pH-responsive polypseudorotaxane Motif13. Ang Chem Int Ed 2007;46:1455-7
  • Chang JH, Shim CH, Kim BJ, Bicontinuous, thermoresponsive, L-3-phase silica nanocomposites and their smart drug-delivery applications. Adv Mater 2005;17:634-7
  • Fu Q, Rao GVR, Ista LK, Control of molecular transport through stimuli-responsive ordered mesoporous materials. Adv Mater 2003;15:1262-6
  • Zhou ZY, Zhu SM, Zhang D. Grafting of thermo-responsive polymer inside mesoporous silica with large pore size using ATRP and investigation of its use in drug release. J Mater Chem 2007;17:2428-33
  • Mal NK, Fujiwara M, Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 2003;421:350-3
  • Liu N, Dunphy R, Atanassov P, Photoregulation of mass transport through a photoresponsive azobenzene-modified nanoporous membrane. Nanolett 2004;4:551-4
  • Lu J, Choi E, Tamanoi F, Light-activated nanoimpeller-controlled drug release in cancer cells. Small 2008;4:421-6.
  • Kim HJ, Matsuda H, Zhou HS, Honma I. Ultrasound-triggered smart drug release from a poly(dimethylsiloxane)-mesoporous silica composite. Adv Mater 2006;18:3083-8
  • Hernández R, Tseng H-R, Wong JW, An operational supramolecular nanovalve. J Am Chem Soc 2004;126:3370-1
  • Nguyen TD, Tseng HR, Celestre PC, A reversible molecular valve. Proc Natl Acad Sci USA 2005;102:10029-34
  • Nguyen TD, Liu Y, Saha S, Design and optimization of molecular nanovalves based on redox-switchable biostable rotaxanes. J Am Chem Soc 2007;129:626-34
  • Angelos S, Yang YW, Patel K, pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes. Angew Chem-Int Edit 2008;47:2222-6
  • Ferris DP, Zhao YL, Khashab NM, Light-operated mechanized nanoparticles. J Am Chem Soc 2009;131:1686-8
  • Arcos D, López-Noriega A, Ruíz-Hernandez E, Ordered mesoporous microspheres for bone grafting and drug delivery. Chem Mat 2009;21:1000-9
  • Manzano M, Aina V, Areán CO, Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization. Chem Eng J 2008;137:30-7
  • Xu W, Gao Q, Xu Y, Controllable release of ibuprofen from size-adjustable and surface hydrophobic mesoporous silica spheres. Powder Tech 2009;191:13-20
  • Zhu YF, Shi JL, Chen HR, A facile method to synthesize novel hollow mesoporous silica spheres and advanced storage property. Microporous Mesoporous Mater 2005;84:218-22
  • Zhu YF, Shi JL, Shen WH, Preparation of novel hollow mesoporous silica spheres and their sustained-release property. Nanotech 2005;16:2633-8
  • Zhu YF, Shi JL, Li YS, Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface. Microporous Mesoporous Mater 2005;85:75-81
  • Zhu YF, Shi JL, Li YS, Hollow mesoporous spheres with cubic pore network as a potential carrier for drug storage and its in vitro release kinetics. J Mater Res 2005;20:54-61
  • Trewyn BG, Giri S, Slowing , Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun 2007;3236-45
  • Giri S, Trewyn BG, Stellmaker MP, Lin VSY. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem-Int Edit 2005;44:5038-44
  • Ruíz-Hernández E, López-Noriega A, Arcos D, Aerosol-assisted synthesis of magnetic mesoporous silica spheres for drug targeting. Chem Mat 2007;19:3455-63
  • Ruíz-Hernández E, López-Noriega A, Arcos D, Vallet-Regí M. Mesoporous magnetic microspheres for drug targeting. Solid State Sci 2008;10:421-6
  • López-Noriega A, Ruíz-Hernández E, Stevens SM, Mesoporous microspheres with doubly ordered core-shell structure. Chem Mat 2009;21:18-20
  • Arruebo M, Galán M, Navascues N, Development of magnetic nanostructured silica-based materials as potential vectors for drug-delivery applications. Chem Mat 2006;18:1911-9
  • Lin Y-S, Hung Y, Su J-K, Gadolinium(III)-incorporated nanosized mesoporous silica as potential magnetic resonance imaging contrast agents. J Phys Chem B 2004;108:15608-11
  • Lin YS, Tsai CP, Huang HY, Well-ordered mesoporous silica nanoparticles as cell markers. Chem Mat 2005;17:4570-3
  • Huang DM, Hung Y, Ko BS, Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. Faseb J 2005;19:2014-6
  • Martin KR. The chemistry of silica and its potential health benefits. J Nutr Health Aging 2007;11:94-8
  • Colilla M, Vallet-Regí M. Novel insights into ordered mesoporous materials for biomedical applications. In: Bioceramics, Preparation and Application. Nova Science Publishers, Inc. New York, USA, 2009. (ISBN 978-1-60741-056-0), [In press]
  • Di Pasqua AJ, Sharma KK, Shi Y-L, Cytotoxicity of mesoporous silica nanomaterials. J Inorg Biochem 2008;102:1416-23
  • Hudson SP, Padera RF, Langer R, Kohane DS. The biocompatibility of mesoporous silicates. Biomaterials 2008;29:4045-55
  • Heikkila T, Salonen J, Tuura J, Mesoporous silica material TUD-1 as a drug delivery system. Int J Pharm 2007;331:133-8
  • Tourne-Peteilh C, Lerner DA, Charnay C, The potential of ordered mesoporous silica for the storage of drugs: The example of a pentapeptide encapsulated in a MSU-Tween 80. ChemPhysChem 2003;4:281-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.